Michael Cruse

Insider Reports History

Location
San Diego, CA
Signature
/s/ Jennifer P. Lam, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael Cruse:

Company Role Class Num Shares Value Price $ Report Date Ownership
Reneo Pharmaceuticals, Inc. Chief Operating Officer Common Stock 35,758 $224,406 $6.28 09 Dec 2022 Direct
Reneo Pharmaceuticals, Inc. Chief Operating Officer Common Stock 13,697 $85,958 $6.28 09 Dec 2022 by Trust
Reneo Pharmaceuticals, Inc. Chief Operating Officer Stock option (right to buy) 125,000 09 Dec 2022 Direct

Insider Reports Filed by Michael Cruse

Symbol Company Period Transactions Value $ Form Type Role Filing Time
OKUR Reneo Pharmaceuticals, Inc. 09 Dec 2022 1 $0 4 Chief Operating Officer 13 Dec 2022, 17:06
OKUR Reneo Pharmaceuticals, Inc. 01 Sep 2022 1 +$25,448 4 Chief Operating Officer 02 Sep 2022, 17:12
OKUR Reneo Pharmaceuticals, Inc. 29 Aug 2022 5 +$23,243 4 Chief Operating Officer 31 Aug 2022, 17:47
OKUR Reneo Pharmaceuticals, Inc. 02 Mar 2022 1 $0 4 Chief Operating Officer 04 Mar 2022, 20:51
OKUR Reneo Pharmaceuticals, Inc. 10 Dec 2021 2 $0 4 Senior VP-Corporate Operations 14 Dec 2021, 15:28
OKUR Reneo Pharmaceuticals, Inc. 25 Aug 2021 1 +$18,616 4 Senior VP-Corporate Operations 26 Aug 2021, 17:51